What are Nanozymes?

-

 



Recent research focuses on artificial enzymes known as nanozymes, which show promise in creating advanced materials for medicine. Scientists aim to understand how nanozymes interact with proteins, goal is to develop nanozymes that are precise and efficient.

About Nanozymes

Nanozymes are synthetic enzymes that mimic natural enzyme functions, which can interact with small molecules but their role with larger proteins is less understood. Research is now expanding to include structural proteins, such as collagen.

Research at CSIR-CLRI

A team at the CSIR-Central Leather Research Institute investigated nanozymes’ interaction with collagen. Led by Dr. Amit Vernekar, the team used a manganese-based oxidase nanozyme (MnN). They demonstrated that MnN could crosslink collagen molecules effectively.

Crosslinking Process

Crosslinking involves linking collagen molecules together. The researchers used tannic acid under mild conditions. This method preserved the natural structure of collagen. It enhanced collagen’s stability, making it resistant to degradation by collagenase.

Artificial Enzyme Design

In another study, researchers embedded an active site in a material called MOF-808. This design mimics natural enzymes’ binding pockets. It improved control over chemical reactions. However, challenges arose with larger proteins like cytochrome c.

Balancing Reactivity

The study marks the need to balance desired and unwanted reactivity. This is crucial when designing artificial enzymes for medical applications. Careful design ensures selectivity and efficiency in enzyme interactions.

Expanding Applications

The research broadens nanozymes’ applications beyond small molecules. It paves the way for developing biomaterials with intact structural properties. Such advancements are essential for therapeutic uses and enhancing material durability. The team’s work reveals how nanozymes can interact with structural proteins. It emphasizes the importance of careful design in creating artificial enzymes. These findings contribute to the fields of biotechnology and medicine.








Comments

Post a Comment

Popular posts from this blog

Japan’s Innovative Approach to Artificial Intelligence Legislation

-
Image
  Japan introduced law aimed at encouraging artificial intelligence (AI) research and development. This legislation, known as the Act on the Promotion of Research, Development and Utilisation of Artificial Intelligence-Related Technologies, seeks to position Japan as a leader in the global AI landscape. The law diverges from stringent regulatory frameworks like the European Union’s AI Act, instead promoting an innovation-driven environment. Key Features of Japan’s AI Law The Act establishes an Artificial Intelligence Strategy Headquarters under the Cabinet. This body is responsible for formulating a national Basic Plan for AI. The plan encompasses foundational research, industrial deployment, international collaboration, and public education. The law avoids rigid regulatory frameworks and focuses on enabling innovation and encouraging cooperation among stakeholders. Comparison with the European Union’s AI Act In contrast to Japan’s approach, the EU’s AI Act employs a risk-based cl...
Read more

EMM-Negative Blood Group System

-
Image
  The International Society of Blood Transfusion officially recognised a new blood group system named EMM-negative, also known as Gwada negative. This designation emerged from the unique case of a woman from Guadeloupe who is the only known individual to possess this rare blood type. The discovery puts stress on advancements in transfusion medicine and genetic research. What is Gwada Negative? Gwada negative refers to the EMM-negative blood group system, identified by the absence of the EMM antigen on red blood cells. This antigen is a high-incidence antigen, present in almost all humans. The lack of such a common antigen is medically and has led to the classification of this blood type as the 48th globally recognised system in transfusion science. Discovery Process The identification of the EMM-negative blood type began in 2011 when the woman underwent routine blood tests. Initial attempts to classify her blood were inconclusive due to the lack of technology. In 2019, advancement...
Read more

Non-Binary AI Chip

-
Image
  China has made leap in artificial intelligence with the deployment of non-binary AI chips. This advancement comes from Professor Li Hongge’s team at Beihang University. They have developed a novel computing approach called Hybrid Stochastic Number (HSN) computing. This innovation aims to address critical limitations in conventional computing. About Hybrid Stochastic Number Computing Hybrid Stochastic Number computing merges traditional binary logic with probabilistic logic. Binary systems operate on precise calculations using 1s and 0s, which are energy-intensive. In contrast, stochastic computing uses voltage signal frequencies to represent values, resulting in lower power consumption but often slower performance. The HSN system combines these approaches to achieve a balance of energy efficiency and computational reliability. Addressing Key Limitations in Conventional Chips Two major limitations challenge conventional chips – the power wall and the architecture wall. The power ...
Read more